C. Venkata S. Ram, MD

home / authors / c-venkata-s-ram-md

Articles

Reduced Cardiovascular Risk and Healthcare Expenditures With Angiotensin Receptor Blocker/ Hydrochlorothiazide

Amy M. Egras, PharmD, BCPS;C. Venkata S. Ram, MD

April 27th 2010

Initial use of fixed-dose angiotensin receptor blocker/hydrochlorothiazide therapy may improve hypertension management, reduce risk of cardiovascular disease, and decrease long-term healthcare expenditures.

Published: June 10th 2025 | Updated: June 12th 2025

Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members

Published: June 2nd 2025 | Updated: June 11th 2025

NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care

Published: June 3rd 2025 | Updated: June 11th 2025

ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape

Published: May 30th 2025 | Updated: June 5th 2025

Emerging Data: Impacts of ROCKstar and AGAVE-201

Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com

Published: April 18th 2025 | Updated: April 21st 2025

Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders

Anatomy of Human Heart on medical background. 3d render - Image credit: ckybe | stock.adobe.com

Published: March 10th 2025 | Updated: March 21st 2025

Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

C. Venkata S. Ram, MD

Articles

Latest Updated Articles